Literature DB >> 36157165

Improved Serotonin Measurement with Fast-Scan Cyclic Voltammetry: Mitigating Fouling by SSRIs.

Chase Stucky1, Michael A Johnson1.   

Abstract

Selective serotonin reuptake inhibitors (SSRIs) have been used for decades to treat disorders linked to serotonin dysregulation in the brain. Moreover, SSRIs are often used in studies aimed at measuring serotonin with fast-scan cyclic voltammetry (FSCV) in living tissues. Here, we show that three different SSRIs - fluoxetine, escitalopram, and sertraline - significantly diminish the faradaic oxidation current of serotonin when employing the commonly used Jackson waveform. Coating carbon-fiber microelectrodes (CFMs) with Nafion resulted in further degradation of peak current, increased response times, and decreased background charging currents compared to bare CFMs. To decrease fouling, we employed a recently published extended serotonin waveform, which scans to a maximum positive potential of +1.3 V, rather than +1.0 V used in the Jackson waveform. Use of this waveform with bare CFMs alleviated the decrease in faradaic current, indicating decreased electrode fouling. Collectively, our results suggest that fouling considerations are important when designing FSCV experiments that employ SSRIs and that they can be overcome by using the appropriate waveform.

Entities:  

Keywords:  SSRIs; carbon-fiber microelectrode; fast-scan cyclic voltammetry; fouling; serotonin

Year:  2022        PMID: 36157165      PMCID: PMC9491377          DOI: 10.1149/1945-7111/ac5ec3

Source DB:  PubMed          Journal:  J Electrochem Soc        ISSN: 0013-4651            Impact factor:   4.386


  42 in total

1.  Subsecond adsorption and desorption of dopamine at carbon-fiber microelectrodes.

Authors:  B D Bath; D J Michael; B J Trafton; J D Joseph; P L Runnels; R M Wightman
Journal:  Anal Chem       Date:  2000-12-15       Impact factor: 6.986

2.  The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects.

Authors:  B Søgaard; H Mengel; N Rao; F Larsen
Journal:  J Clin Pharmacol       Date:  2005-12       Impact factor: 3.126

Review 3.  Association between the serotonin transporter gene and affective disorder: the evidence so far.

Authors:  A D Ogilvie; A J Harmar
Journal:  Mol Med       Date:  1997-02       Impact factor: 6.354

4.  Nafion-CNT coated carbon-fiber microelectrodes for enhanced detection of adenosine.

Authors:  Ashley E Ross; B Jill Venton
Journal:  Analyst       Date:  2012-05-18       Impact factor: 4.616

5.  Carbon microelectrodes with a renewable surface.

Authors:  Pavel Takmakov; Matthew K Zachek; Richard B Keithley; Paul L Walsh; Carrie Donley; Gregory S McCarty; R Mark Wightman
Journal:  Anal Chem       Date:  2010-03-01       Impact factor: 6.986

6.  Nafion-coated electrodes with high selectivity for CNS electrochemistry.

Authors:  G A Gerhardt; A F Oke; G Nagy; B Moghaddam; R N Adams
Journal:  Brain Res       Date:  1984-01-09       Impact factor: 3.252

7.  Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice.

Authors:  L K Heisler; H M Chu; T J Brennan; J A Danao; P Bajwa; L H Parsons; L H Tecott
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Electrocoating carbon fiber microelectrodes with Nafion improves selectivity for electroactive neurotransmitters.

Authors:  M P Brazell; R J Kasser; K J Renner; J Feng; B Moghaddam; R N Adams
Journal:  J Neurosci Methods       Date:  1987-12       Impact factor: 2.390

9.  What has serotonin to do with depression?

Authors:  Philip J Cowen; Michael Browning
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

10.  Serotonin transporter availability increases in patients recovering from a depressive episode.

Authors:  Jonas E Svensson; Cecilia Svanborg; Pontus Plavén-Sigray; Viktor Kaldo; Christer Halldin; Martin Schain; Johan Lundberg
Journal:  Transl Psychiatry       Date:  2021-05-10       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.